Profile
Markus Jerling is currently the Chief Medical Officer at OncoZenge AB. Previously, he held positions as the Director-Drug Safety at Pharmacia Corp.
from 1998 to 2000, Vice President-Clinical Research at CV Therapeutics, Inc. from 2000 to 2004, and Principal at Astra Arcus AB from 1995 to 1998.
He also served as the Chief Medical Officer at Newron Sweden AB. Dr. Jerling obtained his doctorate degree from Karolinska Institutet.
Markus Jerling active positions
| Companies | Position | Start |
|---|---|---|
| ONCOZENGE AB | Chief Tech/Sci/R&D Officer | 30/04/2021 |
Former positions of Markus Jerling
| Companies | Position | End |
|---|---|---|
| KANCERA AB | Chief Tech/Sci/R&D Officer | 31/10/2024 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Chief Tech/Sci/R&D Officer | 31/12/2003 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 31/12/1999 |
Astra Arcus AB | Corporate Officer/Principal | 31/12/1997 |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Chief Tech/Sci/R&D Officer | - |
Training of Markus Jerling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Astra Arcus AB | |
Kancera AB
Kancera AB Pharmaceuticals: MajorHealth Technology Develops drugs against inflammation and cancer | Health Technology |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
- Stock Market
- Insiders
- Markus Jerling
















